1IA
IRMD icon

1620 Investment Advisors’s iRadimed IRMD Stock Holding History

1620 Investment Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Sell
335
-67
-17% -$6.1K 0.02% 366
2026
Q1 		$38.7K Hold
402
– – 0.03% 330
2025
Q4 		$39.1K Hold
402
– – 0.03% 330
2025
Q3 		$28.6K Sell
402
-3
-0.7% -$200 0.02% 351
2025
Q2 		$24.2K Hold
405
– – 0.02% 378
2025
Q1 		$21.3K Hold
405
– – 0.02% 375
2024
Q4 		$22.3K Sell
405
-160
-28% -$8.42K 0.02% 378
2024
Q3 		$28.4K Hold
565
– – 0.02% 366
2024
Q2 		$24.8K Buy
+565
New +$24K 0.02% 369

Other funds holding IRMD

SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

1620 Investment Advisors's IRMD Position: Q2 2026 in Review

1620 Investment Advisors reduced its iRadimed (IRMD) stake by 17% in Q2 2026, selling an estimated $6.1K and leaving 335 shares worth $32K. The position accounts for 0.02% of the portfolio, ranked #366.

1620 Investment Advisors first reported a position in IRMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $39.1K in Q4 2025. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • 1620 Investment Advisors held 335 shares of iRadimed worth $32K as of Q2 2026.
  • 1620 Investment Advisors sold 67 iRadimed shares in Q2 2026, an estimated $6.1K.
  • iRadimed made up 0.02% of 1620 Investment Advisors's portfolio in Q2 2026, its #366 holding.
  • 1620 Investment Advisors first reported a position in iRadimed in Q2 2024 and has held it in 9 quarters since.
  • 1620 Investment Advisors's iRadimed position peaked at $39.1K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.